Health Care & Life Sciences » Biotechnology | China Regenerative Medicine International Ltd.

China Regenerative Medicine International Ltd. | Income Statement

Fiscal year is January-December. All values HKD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,377.00
510.00
2,817.00
27,751.00
755,520.00
72,952
Cost of Goods Sold (COGS) incl. D&A
20,145.00
30,816.00
50,295.00
61,193.00
580,218.00
89,332
Gross Income
18,768.00
30,306.00
47,478.00
33,442.00
175,302.00
16,380
SG&A Expense
55,700.00
106,415.00
122,261.00
251,466.00
444,267.00
530,752
EBIT
74,468.00
136,721.00
169,739.00
-
268,965.00
547,132
Unusual Expense
939.00
146,162.00
101,832.00
8,556.00
23,637.00
786,748
Non Operating Income/Expense
7,283.00
9,726.00
369.00
651.00
56,817.00
4,291
Interest Expense
1,694.00
2,532.00
3,058.00
25,827.00
37,351.50
21,654
Pretax Income
69,374.00
275,248.00
272,528.00
191,198.00
257,739.00
1,352,799
Income Tax
1,890.00
3,951.00
17,136.00
3,326.00
8,415.00
68,884
Consolidated Net Income
67,484.00
271,297.00
255,392.00
194,524.00
249,324.00
1,283,915
Net Income
61,320.00
263,442.00
250,098.00
190,902.00
237,738.00
1,193,501
Net Income After Extraordinaries
61,320.00
263,442.00
250,098.00
190,902.00
237,738.00
1,193,501
Net Income Available to Common
61,320.00
263,442.00
250,098.00
190,902.00
237,738.00
1,193,501
EPS (Basic)
0.01
0.03
0.02
0.01
0.01
1.36
Basic Shares Outstanding
7,409,579.00
9,875,806.00
12,402,512.00
17,309,393.00
17,585,790.00
879,289.50
EPS (Diluted)
0.01
0.03
0.02
0.01
0.01
1.36
Diluted Shares Outstanding
7,409,579.00
9,875,806.00
12,402,512.00
17,309,393.00
17,585,790.00
879,289.50
EBITDA
55,828.00
106,257.00
120,875.00
232,357.00
207,582.00
477,536
Other Operating Expense
-
-
-
768.00
-
-
Non-Operating Interest Income
444.00
441.00
1,732.00
109,562.00
15,397.50
7,026
Minority Interest Expense
6,164.00
7,855.00
5,294.00
3,622.00
11,586.00
90,414

About China Regenerative Medicine International

View Profile
Address
Rooms 3006-10, 30/F
Hong Kong
Hong Kong
Employees -
Website http://www.crmi.hk
Updated 07/08/2019
China Regenerative Medicine International Ltd. is an investment holding company, which engages in in research and development, production and sales of tissue engineering and regenerative medicine products. It operates through the following business segments: Tissue Engineering, Cell, and Cosmetic and Others, and Medical Equipment. The Tissue Engineering segment produces and sells tissue.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.